Modulation of cell death in human colorectal and breast cancer cells through a manganese chelate by involving GSH with intracellular p53 status

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2017-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11010-016-2896-6PMID 28012015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer.

  2014cited by this paper
• ROS and RNS induced apoptosis through p53 and iNOS mediated pathway by a dibasic hydroxamic acid molecule in leukemia cells.

  2014influential reference
• A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer.

  2013influential reference
• Selective induction of apoptosis in various cancer cells irrespective of drug sensitivity through a copper chelate, copper N-(2 hydroxy acetophenone) glycinate: crucial involvement of glutathione

  2013cited by this paper
• Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species

  2012cited by this paper
• Oxidative stress adaptation in aggressive prostate cancer may be counteracted by the reduction of glutathione reductase

  2012cited by this paper
• Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.

  2011influential reference
• Modulation of the vitamin D3 response by cancer-associated mutant p53.

  2010cited by this paper
• Colon cancer: preventive agents and the present status of chemoprevention

  2009cited by this paper
• Identification and Functional Characterization of the Human Glutathione S-Transferase P1 Gene as a Novel Transcriptional Target of the p53 Tumor Suppressor Gene

  2008cited by this paper
• The oncogenic roles of p53 mutants in mouse models.

  2007cited by this paper
• Glutathione Binding to the Bcl-2 Homology-3 Domain Groove

  2007cited by this paper
• Shaping genetic alterations in human cancer: the p53 mutation paradigm.

  2007cited by this paper
• Faculty Opinions recommendation of Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria.

  2007influential reference
• Nrf2 Defends the Lung from Oxidative Stress

  2006cited by this paper
• p53 Regulates Mitochondrial Respiration

  2006cited by this paper
• Drug approval triggers debate on future direction for cancer treatments

  2006cited by this paper
• A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo

  2006cited by this paper
• Silent information regulator 2 (SIRT1) attenuates oxidative stress-induced mesangial cell apoptosis via p53 deacetylation.

  2006cited by this paper
• Targeting multidrug resistance in cancer

  2006cited by this paper
• Free radicals, metals and antioxidants in oxidative stress-induced cancer.

  2006cited by this paper
• Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate.

  2006cited by this paper
• Drug discovery: Playing dirty

  2005cited by this paper
• Manganese Superoxide Dismutase Induces p53-Dependent Senescence in Colorectal Cancer Cells

  2005cited by this paper
• Overexpression of Superoxide Dismutase or Glutathione Peroxidase Protects against the Paraquat + Maneb-induced Parkinson Disease Phenotype*

  2005cited by this paper
• Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.

  2005cited by this paper
• Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

  2004cited by this paper
• Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line

  2004cited by this paper
• Caspase-Independent Cell Death by Arsenic Trioxide in Human Cervical Cancer Cells

  2004cited by this paper
• The Pathophysiology of Mitochondrial Cell Death

  2004cited by this paper
• Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance.

  2003cited by this paper
• World Cancer Report

  2003cited by this paper
• Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity.

  2003cited by this paper
• Puma is an essential mediator of p53-dependent and -independent apoptotic pathways.

  2003cited by this paper
• Synthesis, characterization and biological properties of a novel copper complex.

  2003cited by this paper
• Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line

  2002cited by this paper
• Cancer drugs. Smart weapons prove tough to design.

  2002cited by this paper
• Smart Weapons Prove Tough to Design

  2002cited by this paper
• Butyrate Induces Glutathione S-Transferase in Human Colon Cells and Protects From Genetic Damage by 4-Hydroxy-2-Nonenal

  2001cited by this paper
• Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

  2001cited by this paper
• The role of glutathione S-transferase P1-1 in colorectal cancer: friend or foe?

  2001cited by this paper
• Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration

  2001cited by this paper
• Apoptosis in cancer.

  2000cited by this paper
• Redox signalling and transition metals in the control of the p53 pathway.

  2000cited by this paper
• Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53*

  1999cited by this paper
• Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase.

  1999cited by this paper
• Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.

  1998cited by this paper
• Inhibitors of glutathione S-transferases as therapeutic agents.

  1997cited by this paper
• Studies on adaptation to adriamycin in cells pretreated with hydrogen peroxide.

  1997influential reference
• Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis.

  1996cited by this paper
• Apoptosis in cancer.

  1996cited by this paper
• Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation.

  1995cited by this paper
• Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase.

  1995cited by this paper
• ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.

  1994cited by this paper
• A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.

  1992cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Immunohistochemical localization of glutathione S-transferases alpha, mu, and pi in normal tissue and carcinomas from human colon.

  1991cited by this paper
• Production of large amounts of hydrogen peroxide by human tumor cells.

  1991cited by this paper
• A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

  1991cited by this paper
• The role of glutathione in drug resistance.

  1990cited by this paper
• Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia.

  1990cited by this paper
• Reaction of the antiproliferative and antineoplastic agent trans-bis(salicylaldoximato)copper(II) and related chelates with glutathione and cysteine. Correlation between reactivity and biological activity

  1987cited by this paper
• Metabolism and action of anti-cancer drugs

  1987cited by this paper
• Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU).

  1985cited by this paper
• Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards.

  1985cited by this paper
• Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards.

  1985cited by this paper
• Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

  1974cited by this paper
• Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

  1967cited by this paper

• Schiff bases and cancer drug resistance: key preclinical breakthroughs.

  2025cites this paper
• Targeting Metal Ion Homeostasis for Regulated Cell Death-Amplified Tumor Nanomedicine

  2025cites this paper
• Plasticity of Tumor Suppressor Functionality of p53 Includes Potential Carcinogenesis in Terms of Subsequent Progression of the Malignant Transformation Event

  2018cites this paper